112 related articles for article (PubMed ID: 15955854)
41. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease.
Mazari FA; Khan JA; Carradice D; Samuel N; Abdul Rahman MN; Gulati S; Lee HL; Mehta TA; McCollum PT; Chetter IC
Br J Surg; 2012 Jan; 99(1):39-48. PubMed ID: 22021102
[TBL] [Abstract][Full Text] [Related]
42. Endovascular brachytherapy with (192)Ir and (188)Re to treat de novo and recurrent infrainguinal restenoses.
Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
J Cardiovasc Surg (Torino); 2010 Aug; 51(4):573-8. PubMed ID: 20671642
[TBL] [Abstract][Full Text] [Related]
43. A Phase II study of external-beam radiotherapy and endovascular brachytherapy with PTA and stenting for femoropopliteal artery restenosis.
Narayan K; Denton M; Das R; Bernshaw D; Rolfo A; van Dyk S; Mirakian A
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):238-43. PubMed ID: 16820271
[TBL] [Abstract][Full Text] [Related]
44. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
Radak Dj; Laps KH; Jeger KA; Ilijevski N; Vojić M
Srp Arh Celok Lek; 1998; 126(3-4):83-91. PubMed ID: 9863361
[TBL] [Abstract][Full Text] [Related]
45. Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries.
Karch LA; Mattos MA; Henretta JP; McLafferty RB; Ramsey DE; Hodgson KJ
J Vasc Surg; 2000 May; 31(5):880-7. PubMed ID: 10805877
[TBL] [Abstract][Full Text] [Related]
46. The role of radiation therapy in the treatment of femoropopliteal occlusive disease.
Chellini J; Ansel GM; Botti CF; Silver MJ
J Invasive Cardiol; 2003 Jan; 15 Suppl A():21A-24A. PubMed ID: 12668838
[TBL] [Abstract][Full Text] [Related]
47. Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: a metaanalysis of randomized trials.
E Y; He N; Wang Y; Fan H
J Vasc Interv Radiol; 2008 Apr; 19(4):499-503. PubMed ID: 18375292
[TBL] [Abstract][Full Text] [Related]
48. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
49. Intravascular ultrasound predictors of restenosis after balloon angioplasty of the femoropopliteal artery.
van der Lugt A; Gussenhoven EJ; Pasterkamp G; Stijnen T; Reekers JA; van den Berg FG; Tielbeek AV; Seelen JL; Pieterman H
Eur J Vasc Endovasc Surg; 1998 Aug; 16(2):110-9. PubMed ID: 9728429
[TBL] [Abstract][Full Text] [Related]
50. External beam radiation to prevent restenosis after superficial femoral artery balloon angioplasty.
Therasse E; Donath D; Lespérance J; Tardif JC; Guertin MC; Oliva VL; Soulez G
Circulation; 2005 Jun; 111(24):3310-5. PubMed ID: 15956130
[TBL] [Abstract][Full Text] [Related]
51. Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions.
Iida O; Nanto S; Uematsu M; Morozumi T; Kitakaze M; Nagata S
J Vasc Surg; 2008 Jul; 48(1):144-9. PubMed ID: 18482817
[TBL] [Abstract][Full Text] [Related]
52. Percutaneous transluminal angioplasty and enclosed thrombolysis versus percutaneous transluminal angioplasty in the treatment of femoropopliteal occlusions: results of a prospective randomized trial.
Nicholson T
Cardiovasc Intervent Radiol; 1998; 21(6):470-4. PubMed ID: 9853164
[TBL] [Abstract][Full Text] [Related]
53. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.
Malas MB; Enwerem N; Qazi U; Brown B; Schneider EB; Reifsnyder T; Freischlag JA; Perler BA
J Vasc Surg; 2014 Jan; 59(1):129-35. PubMed ID: 23891488
[TBL] [Abstract][Full Text] [Related]
54. Adjunctive abciximab improves patency and functional outcome in endovascular treatment of femoropopliteal occlusions: initial experience.
Dörffler-Melly J; Mahler F; Do DD; Triller J; Baumgartner I
Radiology; 2005 Dec; 237(3):1103-9. PubMed ID: 16304122
[TBL] [Abstract][Full Text] [Related]
55. Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes.
Robinson WP; Nguyen LL; Bafford R; Belkin M
J Vasc Surg; 2011 Mar; 53(3):651-7. PubMed ID: 21129908
[TBL] [Abstract][Full Text] [Related]
56. Mid-term outcome after endovascular therapy in the superficial femoral and popliteal artery using long stents.
Schoenefeld E; Donas KP; Schönefeld T; Osada N; Austermann M; Torsello G
Vasa; 2012 Jan; 41(1):49-56. PubMed ID: 22247060
[TBL] [Abstract][Full Text] [Related]
57. Nurr1 haplotypes are associated with femoropopliteal restenosis/re-occlusion after percutaneous transluminal angioplasty.
Božič-Mijovski M; Bedenčič M; Stegnar M; Salapura V; Ježovnik MK; Kozak M; Blinc A
Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):337-8. PubMed ID: 22230598
[TBL] [Abstract][Full Text] [Related]
58. [Endovascular Ir-192 HDR brachytherapy for avoidance of intimal hyperplasia in peripheral vessels after PTA and stent implantation. A 6-year experience].
Böttcher HD; Schopohl B
Strahlenther Onkol; 1998 Mar; 174(3):115-20. PubMed ID: 9524619
[TBL] [Abstract][Full Text] [Related]
59. Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study.
Pokrajac B; Schmid R; Kirisits C; Mock U; Fellner C; Wambersie A; Pötter R; Minar E
Radiother Oncol; 2002 Apr; 63(1):97-102. PubMed ID: 12065109
[TBL] [Abstract][Full Text] [Related]
60. Present status of endovascular brachytherapy in peripheral arteries.
Pokrajac B; Minar E; Kirisits C; Pötter R
Herz; 2002 Feb; 27(1):56-61. PubMed ID: 11951795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
